Antibiotic susceptibility of isolated H. pylori strains was performed by the E-test (BioMérieux) determining the minimum inhibitory concentrations (MICs) against amoxicillin, clarithromycin, levofloxacin, metronidazole, rifampicin, and tetracycline. A bacterial suspension was prepared in BB supplemented with 10% HS and 200 μL of this suspension was transferred onto the surface of the MHB and streaked with a cotton swab. Antibiotic strips were applied onto the surface of inoculated and dried agar plates. The plates were incubated in a microaerophilic incubator (VAIN) at 37 °C for 72 h before examination. MIC was determined by considering the point where ellipse growth cut with the scale number in the E-test strip. The breakpoints were defined as follows: amoxicillin, MIC > 0.125 μg/mL; clarithromycin, MIC > 0.5 μg/mL; levofloxacin, MIC > 1 μg/mL; metronidazole, MIC > 8 μg/mL; rifampicin, MIC > 1 μg/mL; and tetracycline, MIC > 1 μg/mL, following the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines (version 8.0). Strain Hp11637 (NCTC) was used as experimental control.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.